Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Brentuximab for second-line lymphoma treatment

Alison Moskowitz, MD, of the Memorial Sloan Kettering Cancer Center, New York, NY, talks about the use of brentuximab in the second-line treatment of lymphoma. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.